A Cambridge man spent National Donut Day biking to every Dunkin' in Boston to raise money for multiple sclerosis research.

A second-generation anti-CD40 therapy that inhibits B- and T-cell activity nearly eliminated multiple sclerosis activity over ...

Researchers still don’t fully understand the cause of multiple sclerosis or why the rate of progression is so difficult to ...

Researchers say the smartphone app could empower patients to better understand their disease and make disease management ...

Multiple sclerosis MS a chronic neurological condition is an autoimmune disorder Scroll down to learn how to identify the ...

MS prevalence has increased by about one-third in New Zealand in recent decades, though some barriers to diagnosis still ...

Despite its growing role in tracking MS activity, serum neurofilament light chain lacks diagnostic specificity, experts say.

A Cambridge man spent National Donut Day biking to every Dunkin' in Boston to raise money for multiple sclerosis research.

Early diagnosis and treatment aim to minimise the impact of multiple sclerosis on their daily lives and extend their ...

CNW/ - EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany in the US and Canada, is pleased to ...

A University of Auckland study reveals the number of people diagnosed with the chronic condition lifted by a third between 2006 and 2022. Study author Natalia Boven says while European New Zealanders ...

While a lot of people are relaxing on Memorial Day weekend, one Colorado woman is spending her week raising awareness about ...